Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,907
Total Claims
$1.0M
Drug Cost
812
Beneficiaries
$1,262
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 44,021 Emergency Medicine providers
-83%
Opioid rate vs peers
1.6% vs 9.4% avg
+729%
Brand preference vs peers
12.3% vs 1.5% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.6%
Opioid Rate
144
Opioid Claims
$812
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,079 claims · $889K
Generic: 7,690 claims · $132K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 72 | $168K |
| Dapagliflozin Propanediol | 122 | $147K |
| Empagliflozin | 60 | $71K |
| Semaglutide | 33 | $58K |
| Sitagliptin Phosphate | 23 | $37K |
| Budesonide/Glycopyr/Formoterol | 35 | $28K |
| Apixaban | 34 | $23K |
| Linagliptin | 14 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $20K |
| Fluticasone/Umeclidin/Vilanter | 18 | $18K |
| Budesonide/Formoterol Fumarate | 27 | $17K |
| Insulin Glargine/Lixisenatide | 13 | $12K |
| Linaclotide | 12 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $9,883 |
| Insulin Nph Hum/Reg Insulin Hm | 32 | $9,867 |
Prescribing Profile
Patient Profile
69
Avg Age
57%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data